Cargando…
Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study
The gut microbiota system plays a vital role in liver diseases. This study aimed to address the diversity of gut microbiota and its correlations with clinical parameters in healthy individuals, chronic liver disease (CLD), and hepatocellular carcinoma (HCC) patients. Fecal specimens of nine healthy...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806631/ https://www.ncbi.nlm.nih.gov/pubmed/34592890 http://dx.doi.org/10.1080/21655979.2021.1982273 |
_version_ | 1784643496478507008 |
---|---|
author | Chen, Tianyou Ding, Rongrong Chen, Xiaorong Lu, Yunfei Shi, Jia Lü, Ying Tang, Bozong Zhang, Wensi Ye, Chen Yuan, Min Yang, Zongguo |
author_facet | Chen, Tianyou Ding, Rongrong Chen, Xiaorong Lu, Yunfei Shi, Jia Lü, Ying Tang, Bozong Zhang, Wensi Ye, Chen Yuan, Min Yang, Zongguo |
author_sort | Chen, Tianyou |
collection | PubMed |
description | The gut microbiota system plays a vital role in liver diseases. This study aimed to address the diversity of gut microbiota and its correlations with clinical parameters in healthy individuals, chronic liver disease (CLD), and hepatocellular carcinoma (HCC) patients. Fecal specimens of nine healthy individuals, 11 CLD, and 21 HCC were collected. The diversity of gut microbiota was examined by PCR and Illumina MiSeq sequencing and analyzed using 16S rRNA gene sequencing database. The correlations between gut microbiota and the clinical parameters of participants were also addressed. Compared to healthy individuals, Firmicutes at a phylum level decreased in CLD and HCC patients and Proteobacteria increased (p < 0.05). The composition of Blautia on a genus level in CLD and HCC patients significantly decreased compared to healthy controls (p < 0.05). Firmicutes composition was negatively associated with age and number of males (p < 0.05) and was positively associated with monocytes, high-density lipoprotein cholesterol (HDL-C), and estimated glomerular filtration rate (eGFR) levels (p < 0.05). At a genus level, Blautia composition was negatively associated with cirrhosis, age, and number of males (p < 0.01), while it was positively associated with red blood cells (RBCs), triglycerides, HDL-C, and lymphocyte levels (p < 0.05). Conclusively, there was a significant compositional difference in gut microbiota in CLD and HCC patients compared with healthy subjects. Firmicutes and Blautia in gut microbiota system lessened in CLD and HCC patients. Clinical biochemical parameters have an impact on the diversity of gut microbiota in liver diseases. |
format | Online Article Text |
id | pubmed-8806631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88066312022-02-02 Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study Chen, Tianyou Ding, Rongrong Chen, Xiaorong Lu, Yunfei Shi, Jia Lü, Ying Tang, Bozong Zhang, Wensi Ye, Chen Yuan, Min Yang, Zongguo Bioengineered Research Paper The gut microbiota system plays a vital role in liver diseases. This study aimed to address the diversity of gut microbiota and its correlations with clinical parameters in healthy individuals, chronic liver disease (CLD), and hepatocellular carcinoma (HCC) patients. Fecal specimens of nine healthy individuals, 11 CLD, and 21 HCC were collected. The diversity of gut microbiota was examined by PCR and Illumina MiSeq sequencing and analyzed using 16S rRNA gene sequencing database. The correlations between gut microbiota and the clinical parameters of participants were also addressed. Compared to healthy individuals, Firmicutes at a phylum level decreased in CLD and HCC patients and Proteobacteria increased (p < 0.05). The composition of Blautia on a genus level in CLD and HCC patients significantly decreased compared to healthy controls (p < 0.05). Firmicutes composition was negatively associated with age and number of males (p < 0.05) and was positively associated with monocytes, high-density lipoprotein cholesterol (HDL-C), and estimated glomerular filtration rate (eGFR) levels (p < 0.05). At a genus level, Blautia composition was negatively associated with cirrhosis, age, and number of males (p < 0.01), while it was positively associated with red blood cells (RBCs), triglycerides, HDL-C, and lymphocyte levels (p < 0.05). Conclusively, there was a significant compositional difference in gut microbiota in CLD and HCC patients compared with healthy subjects. Firmicutes and Blautia in gut microbiota system lessened in CLD and HCC patients. Clinical biochemical parameters have an impact on the diversity of gut microbiota in liver diseases. Taylor & Francis 2021-10-19 /pmc/articles/PMC8806631/ /pubmed/34592890 http://dx.doi.org/10.1080/21655979.2021.1982273 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Chen, Tianyou Ding, Rongrong Chen, Xiaorong Lu, Yunfei Shi, Jia Lü, Ying Tang, Bozong Zhang, Wensi Ye, Chen Yuan, Min Yang, Zongguo Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title | Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title_full | Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title_fullStr | Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title_full_unstemmed | Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title_short | Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
title_sort | firmicutes and blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806631/ https://www.ncbi.nlm.nih.gov/pubmed/34592890 http://dx.doi.org/10.1080/21655979.2021.1982273 |
work_keys_str_mv | AT chentianyou firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT dingrongrong firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT chenxiaorong firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT luyunfei firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT shijia firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT luying firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT tangbozong firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT zhangwensi firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT yechen firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT yuanmin firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy AT yangzongguo firmicutesandblautiaingutmicrobiotalessenedinchronicliverdiseasesandhepatocellularcarcinomapatientsapilotstudy |